Development and validation of an interpretable machine learning model for predicting systemic inflammatory response
Leibo Wang1, Wei He2, Tao Qiu1
1Department of Urology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
International Journal of Medical Informatics
|June 30, 2026
Summary
A machine learning model accurately predicts Systemic Inflammatory Response Syndrome (SIRS) after percutaneous nephrolithotomy (PCNL) using routine data. This tool aids early risk stratification for better patient outcomes.
Area of Science:
- Urology
- Nephrology
- Medical Informatics
Background:
- Systemic Inflammatory Response Syndrome (SIRS) is a frequent complication post-percutaneous nephrolithotomy (PCNL).
- Current risk prediction models for SIRS lack generalizability and interpretability.
- Timely intervention requires accurate perioperative risk stratification.
Purpose of the Study:
- To develop and validate an interpretable machine learning model for predicting SIRS after PCNL.
- To identify key perioperative predictors of postoperative SIRS.
- To improve clinical decision-making for infectious complications.
Main Methods:
- Multicenter retrospective cohort study (2,684 patients).
- Feature selection using LASSO regression and Boruta algorithm.
- Development and comparison of seven machine learning models, with AUPRC as the primary metric.
- Validation using internal and external cohorts, with calibration and SHAP analysis for interpretability.
Main Results:
- Six consistent predictors identified: stone size, urine nitrite, urine culture, operative time, residual stone, and neutrophil-to-albumin ratio.
- Random forest model demonstrated balanced performance (AUPRC 0.581-0.641, AUROC 0.873-0.920).
- SHAP analysis confirmed clinically relevant, non-linear predictor associations; an online tool was created.
Conclusions:
- An interpretable ML model using routine perioperative data reliably predicts SIRS post-PCNL.
- This model facilitates early risk stratification and timely clinical decisions.
- Further prospective and multi-regional validation is recommended.

